α7 Nicotinic receptor modulators for cognitive deficits in schizophrenia and Alzheimer's disease

Hugo Geerts
  • Expert Opinion on Investigational Drugs, November 2011, Informa Healthcare
  • DOI: 10.1517/13543784.2012.633510

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1517/13543784.2012.633510

The following have contributed to this page: Hugo Geerts